Výsledky vyhledávání - "Anthony J, Rodgers"

Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK

Autor: Edwin, DeJesus, Jürgen K, Rockstroh, Jeffrey L, Lennox, Michael S, Saag, Adriano, Lazzarin, Jing, Zhao, Hong, Wan, Anthony J, Rodgers, Monica L, Walker, Michael, Miller, Mark J, DiNubile, Bach-Yen, Nguyen, Hedy, Teppler, Randi, Leavitt, Peter, Sklar, D, Wright

Publikováno v: HIV clinical trials. 13(4)

We compared 4 years of antiretroviral therapy with tenofovir/emtricitabine and either raltegravir or efavirenz from the ongoing STARTMRK study of treatment-naive HIV-infected patients. Through 192 weeks, raltegravir produced durable and consistent vi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e2be1b482aed6e9fbc603e475dc45ce
https://pubmed.ncbi.nlm.nih.gov/22849964

Zobrazit plný text záznamu

Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses

Autor: Jeffrey L, Lennox, Edwin, Dejesus, Daniel S, Berger, Adriano, Lazzarin, Richard B, Pollard, Jose Valdez, Ramalho Madruga, Jing, Zhao, Hong, Wan, Christopher L, Gilbert, Hedy, Teppler, Anthony J, Rodgers, Richard J O, Barnard, Michael D, Miller, Mark J, Dinubile, Bach-Yen, Nguyen, Randi, Leavitt, Peter, Sklar, D, Wright

Publikováno v: Journal of acquired immune deficiency syndromes (1999). 55(1)

BACKGROUND We analyzed the 96-week results in the overall population and in prespecified subgroups from the ongoing STARTMRK study of treatment-naive HIV-infected patients. METHODS Eligible patients with HIV-1 RNA (vRNA) levels >5000 copies per milli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043accdc2ae85dfd7e0caa2e6d4cec71
https://pubmed.ncbi.nlm.nih.gov/20404738

Zobrazit plný text záznamu

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

Publikováno v: Lancet (London, England). 375(9712)

To reduce lipid abnormalities and other side-effects associated with antiretroviral regimens containing lopinavir-ritonavir, patients might want to switch one or more components of their regimen. We compared substitution of raltegravir for lopinavir-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d85b62239e2d532140dd22c3b391d97d
https://pubmed.ncbi.nlm.nih.gov/20074790

Zobrazit plný text záznamu

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Autor: Jeffrey L, Lennox, Edwin, DeJesus, Adriano, Lazzarin, Richard B, Pollard, Jose Valdez Ramalho, Madruga, Daniel S, Berger, Jing, Zhao, Xia, Xu, Angela, Williams-Diaz, Anthony J, Rodgers, Richard J O, Barnard, Michael D, Miller, Mark J, DiNubile, Bach-Yen, Nguyen, Randi, Leavitt, Peter, Sklar, D, Wright

Publikováno v: Lancet (London, England). 374(9692)

Use of raltegravir with optimum background therapy is effective and well tolerated in treatment-experienced patients with multidrug-resistant HIV-1 infection. We compared the safety and efficacy of raltegravir with efavirenz as part of combination an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ae4f1f3f28798942baec19d39cae2dc
https://pubmed.ncbi.nlm.nih.gov/19647865

Zobrazit plný text záznamu

Akademický článek

The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain.

Autor: Jacques E. Chelly, Carl W. Nissen, Anthony J. Rodgers, Steven S. Smugar, Andrew M. Tershakovec

Publikováno v: Current Medical Research & Opinion; Jan2007, Vol. 23 Issue 1, p195-206, 12p

Zobrazit plný text záznamu

Akademický článek

Calculation of Phase 2 dose‐finding study sample size for reliable Phase 3 dose selection.

Autor: Liu, Fang, Zhao, Qing, Rodgers, Anthony J., Mehrotra, Devan V.

Publikováno v: Pharmaceutical Statistics; Nov/Dec2023, Vol. 22 Issue 6, p1076-1088, 13p

Zobrazit plný text záznamu

Akademický článek

Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1-Infected Patients.

Autor: Rockstroh, Jürgen K., DeJesus, Edwin, Lennox, Jeffrey L., Yazdanpanah, Yazdan, Saag, Michael S., Wan, Hong, Rodgers, Anthony J., Walker, Monica L., Miller, Michael, DiNubile, Mark J., Nguyen, Bach-Yen, Teppler, Hedy, Leavitt, Randi, Sklar, Peter

Publikováno v: JAIDS: Journal of Acquired Immune Deficiency Syndromes; 5/1/2013, Vol. 63 Issue 1, p77-85, 9p

Zobrazit plný text záznamu

Akademický článek

Clinical Infectious Diseases.

Publikováno v: Clinical Infectious Diseases; 10/15/2011, Vol. 53 Issue 8, p1-1, 1p

Zobrazit plný text záznamu

Elektronická kniha

Managing Human Behavior in Public and Nonprofit Organizations

Autor: Robert B. Denhardt, Janet V. Denhardt, Maria P. Aristigueta, Kelly C. Rawlings

'This is a well-thought-out and well-researched textbook on human behavior and relations in organizations....The extensive use of case studies and examples makes the material easy to grasp and apply.'—M.S. Kinoti, Ph.D., Regis University Managing H

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání